
|Articles|July 15, 2006
Prophylactic, therapeutic use of mitomycin-C considered safe
Literature review shows single application of low-dose MMC can prevent, treat haze after surface procedures
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: A new biomechanical paradigm for presbyopia
2
AAO 2025 Takeaways: The new era of glaucoma treatment and surgical precision
3
AAO 2025 Takeaways: Cornea, refractive surgery, and aesthetics redefined
4
Managing Unique Dry Eye Disease Subtypes in Patients
5

















































.png)


